📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor. (2023)

First Author: Fiol CR

Attributed to: FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2023.06.011

PubMed Identifier: 37528866

Publication URI: http://europepmc.org/abstract/MED/37528866

Type: Journal Article/Review

Volume: 30

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501